Cargando…

Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir

BACKGROUND: Immunocompromised populations, such as organ transplant recipients and patients with inflammatory bowel disease (IBD) receiving immunosuppressive/immunomodulatory medications, may be more susceptible to coronavirus infections. However, little is known about how immunosuppressants affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yining, Li, Pengfei, Lavrijsen, Marla, Rottier, Robbert J., den Hoed, Caroline M., Bruno, Marco J., Kamar, Nassim, Peppelenbosch, Maikel P., de Vries, Annemarie C., Pan, Qiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256998/ https://www.ncbi.nlm.nih.gov/pubmed/37226653 http://dx.doi.org/10.1002/ueg2.12417

Ejemplares similares

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses
por: Li, Jiajing, et al.
Publicado: (2023)

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids
por: Li, Pengfei, et al.
Publicado: (2022)

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
por: Wang, Yining, et al.
Publicado: (2023)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
por: Fung, Kin Wah, et al.
Publicado: (2023)

New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
por: Atmar, Robert L., et al.
Publicado: (2022)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2023)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study
por: Julien, Karen, et al.
Publicado: (2020)

Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans
por: Guler, Ezgi, et al.
Publicado: (2020)

Feasibility and safety of bedside percutaneous biliary drainage in patients with severe cholangitis
por: Gupta, Pankaj, et al.
Publicado: (2020)

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients
por: Medeiros, Augusto Kreling, et al.
Publicado: (2020)

CT of amebic liver abscess: different morphological types with different clinical features
por: Priyadarshi, Rajeev Nayan, et al.
Publicado: (2021)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics
por: Silva, Mario, et al.
Publicado: (2021)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort
por: Llop, Elba, et al.
Publicado: (2021)

Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography
por: Huang, Hsin-Chih, et al.
Publicado: (2021)

Portosystemic shunt surgery in the era of TIPS: imaging-based planning of the surgical approach
por: Fehrenbach, Uli, et al.
Publicado: (2020)

CT angiography of abdomen and pelvis in critically ill COVID-19 patients: imaging findings and correlation with the CT chest score
por: Vadvala, Harshna V., et al.
Publicado: (2021)

Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents
por: Thrane, Karl Julius, et al.
Publicado: (2021)

Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2
por: Jiang, Hao, et al.
Publicado: (2021)

Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance
por: Zimmermann, Lisa, et al.
Publicado: (2021)

Reproducibility of liver R2* quantification for liver iron quantification from cardiac R2* acquisitions
por: Muehler, M. R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bj9i3mn1itntv0tv8sl6vs4r1u